Importantly, in all in vitro and in vivo experiments in this study, ATSP-7041 and NSC207895 showed anti-tumor effects by reactivating p53 signaling leading to decreased cellular proliferation and apoptosis. This evidence concerns the gene TP53 and neoplasm.